Regenerative Medicine Research News:
The liver possesses some capacity to regenerate or heal itself after injury. When the liver is damaged beyond this capacity, a whole-liver transplant is the preferred treatment of many medical professionals, but the demand for donor livers far exceeds supply. Thus, scientists are developing regenerative medicine therapies to treat damaged livers.Human hepatocytes have been generated in vitro from induced pluripotent stem cells (iPSC), but these cells do not adequately proliferate and function after transplantation into mouse models of liver damage for therapeutic success.
In a study published in Nature Feb 23, 2014, UCSF scientists describe how they developed an induced multipotent progenitor cell (iMPC) reprogramming technique to differentiate
